Summary
A screening for androgen-regulated genes in prostate cancer (PCA) cells revealed that androgenes, apart from their well known effects on cell survival, proliferation, and differentiation, stimulate the expression of several lipogenic genes, including the gene encoding fatty acid synthase (FAS). FAS, a key enzyme in the biosynthesis of fatty acids, is markedly overexpressed in many epithelial cancers including cancer of the prostate, breast, ovary and endometrium. To gain more insight into the role of FAS in cancer cells and to explore its potential as a novel target for antineoplastic therapy, we have used the potent and highly sequence-specific technique of RNA interference (RNAi) to silence FAS in LNCaP prostate cancer cells. RNAi-mediated down-regulation of FAS expression resulted in a major decrease in the synthesis of triglycerides and of phospholipids partitioning into detergent-resistant membrane microdomains. These effects were accompanied by marked morphological changes, including a reduction in cell volume, a loss of cell-cell contacts, and the formation of spider-like extrusions. Furthermore, silencing of the FAS gene by RNAi significantly inhibited LNCaP cell growth and ultimately resulted in induction of apoptosis. In striking contrast with LNCaP cells, RNAi-mediated inhibition of FAS did not influence viability of nonmalignant fibroblasts. The data presented herein suggest that overexpression of FAS induced by hormones, growth factors, or other mechanisms may play an important role in cancer cell biology, and that RNA interference, particularly targeting lipogenic genes, constitutes a promising tool for the development of new cancer treatments.
Keywords
- LNCaP Cell
- Lipogenic Gene
- LNCaP Prostate Cancer Cell
- Lipogenic Gene Expression
- Inhibit Prostate Cancer Cell Growth
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Swinnen JV, Van Veldhoven PP, Esquenet M, et al (1996) Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology 137:4468–4474.
Swinnen JV, Esquenet M, Goossens, et al (1997) Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res. 57:1086–1090.
Wakil SJ (1989) Fatty acid synthase, a proficient multifunctional enzyme, Biochemistry 28:4523–4530.
Weiss L, Hoffmann GE, Schreiber R, et al (1986) Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppes-Seyer 367:905–912.
Kuhajda FP (2000) Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16:202–208.
Piyathilake CJ, Frost AR, Manne, et al (2000) The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum Pathol 31:1068–1073.
Swinnen JV, Roskams T, Joniau S, et al (2002) Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer 98:19–22.
Kusakabe T, Nashimoto A, Honma, et al (2002) Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 40:71–79.
Swinnen JV, Vanderhoydonc F, Elgamal AA, et al (2000) Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 88:176–179.
Milgraum LZ, Witters LA, Pasternack GR, et al (1997) Enzymes of the fatty acid synthase are highly expressed in in situ breast carcinoma. Clin Cancer Res 3:2115–2120.
Swinnen JV, Heemers H, Deboel, et al (2000) Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene 19:5173–5181.
Li JN, Mahmoud MA, Han WF, et al (2000) Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp Cell Res 261:159–165.
Swinnen JV, Ulrix W, Heyns W, et al (1997) Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 94:12975–12980.
Heemers H, Maes B, Foufelle, et al (2001) Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 15:1817–1828.
Van de Sande T, De Schrijver E, Heyns W, et al (2002) Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res 62:642–646.
Pizer ES, Chrest FJ, DiGiuseppe JA, et al (1998) Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res 58:4611–4615.
Kuhajda FP, Pizer ES, Li JN, et al (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 97:3450–3454.
Pizer ES, Wood FD, Heine HS, et al (1996) Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res 56:1189–1193.
Pizer ES, Jackisch C, Wood FD, et al (1996) Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res 56:2745–2747.
Li JN, Gorospe M, Chrest FJ, et al (2001) Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res 61:1493–1499.
Lawrence DS, Zilfou JT, Smith CD (1999) Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors. J Med Chem 42:4932–4941.
Malvoisin E, Wild F (1990) Effect of drugs which inhibit cholesterol synthesis on syncytia formation in vero cells infected with measles virus. Biochim Biophys Acta 1042:359–364.
Moelling K, Schulze T, Knoop MT, et al (1990) In vitro inhibition of HIV-1 proteinase by cerulenin. FEBS Lett 261:373–377.
Ikuta K, Luftig RB (1986) Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin. Virology 154:195–206.
Zamore PD, Tuschl T, Sharp PA, et al (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25–33.
Elbashir SM, Harborth J, Lendeckel W, et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498.
De Schrijver E, Brusselmans K, Heyns W, et al (2003) RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res 63:3799–3804.
Swinnen J, Van Veldhoven P, Timmermans L, et al (2003). Fatty acid synthase drives the synthesis of phospholipids partioning into detergent-resistant membrane microdomains. Biochem Biophys Res Com 302:898–903.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
De Schrijver, E., Brusselmans, K., Heyns, W., Verhoeven, G., Swinnen, J.V. (2005). Silencing of the Fatty Acid Synthase Gene by RNA Interference Inhibits Growth and Induces Apoptosis of LNCaP Prostate Cancer Cells. In: Li, J.J., Li, S.A., Llombart-Bosch, A. (eds) Hormonal Carcinogenesis IV. Springer, Boston, MA. https://doi.org/10.1007/0-387-23761-5_33
Download citation
DOI: https://doi.org/10.1007/0-387-23761-5_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23783-1
Online ISBN: 978-0-387-23761-9
eBook Packages: MedicineMedicine (R0)